Latest News & Features
Big Pharma
A Takeda subsidiary cannot overturn a $155 million jury verdict that it infringed one of Bayer’s patents, a district court has ruled. 27 August 2019
Big Pharma
Amgen has entered into an agreement with Celgene to acquire worldwide rights to Otezla, the only oral, non-biologic treatment for psoriasis and psoriatic arthritis, for $13.4 billion. 27 August 2019
Big Pharma
The US Federal Trade Commission (FTC) has approved a final order settling charges that healthcare company UnitedHealth’s $4.3 billion acquisition of DaVita Medical would harm competition. 23 August 2019
Americas
Gilead Sciences, the maker of HIV drug Truvada, has asked the US Patent and Trademark Office to review patents granted to the government covering preventative use of the drug. 22 August 2019
Generics
Danish pharmaceutical company Novo Nordisk has sued Mylan in a US court over a proposed generic of diabetes drug Victoza (liraglutide). 22 August 2019
Big Pharma
A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products. 21 August 2019
Americas
Bayer has agreed to sell its animal health business to US-based Elanco Animal Health for $7.6 billion, as part of its strategic plan to focus on its core life sciences businesses. 21 August 2019
Americas
Amneal and three other generic makers have agreed to pay $1.54 million to settle a class-action lawsuit, which alleged the companies engaged in an unlawful scheme to maintain their monopoly over an Alzheimer’s drug. 20 August 2019
Americas
The US and Europe have reached the same conclusion in more than 90% of marketing authorisation decisions for new medicines, according to a report from the European Medicines Agency. 19 August 2019
Big Pharma
Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit. 16 August 2019